Twitter Logo Youtube Circle Icon LinkedIn Icon

United States > Dispute resolution > Product liability, mass tort and class action: pharmaceuticals and medical devices - plaintiff > Law firm and leading lawyer rankings


Index of tables

  1. Product liability, mass tort and class action: pharmaceuticals and medical devices - plaintiff
  2. Leading lawyers

Leading lawyers

  1. 1

Burg Simpson Eldredge Hersh & Jardine, P.C.’s ‘outstanding’ practice is headed by Michael Burg, who served as co-lead counsel in an MDL comprising more than 14,000 claims brought against Bayer regarding its oral contraceptive drug. In addition to serving on the plaintiffs’ executive committee in In re: Testosterone Replacement Therapy Products Liability Litigation, the ‘very knowledgeableSeth Katz continues to serve as a member of the plaintiffs’ steering committee in an MDL against DePuy Synthes concerning its recalled ASR XL metal-on-metal hip device and allegations of defects in its ASR XL Acetabular Hip System. Peter Burg is a member of the plaintiffs’ steering committee of the California Joint Coordinated Case Proceeding (JCCP) in the consolidated litigation regarding Wright Medical Group’s metal-on-metal hip implants, which plaintiffs alleged resulted in a risk of metallosis toxicity, as well as an increased risk of hip failure. All partners mentioned are based in Denver.

Herman, Herman & Katz LLC’s New Orleans-based team has substantial experience in handling pharmaceutical product liability litigation, with a particular expertise in electronic discovery. Leonard Davis, James Klick and of counsel Joseph Kott are leading representation of plaintiffs against DePuy Synthes concerning allegations of defects in its ASR hip implants in the Northern District of Ohio. The firm also filed numerous product liability claims on behalf of individuals against Fresenius regarding the kidney dialysis drug GranuFlo. Davis, Maury Herman and Russ Herman are also involved in litigation against numerous pharmaceuticals manufacturers such as AbbVie and Abbott Laboratories alleging defects in the defendants’ testosterone replacement therapy products.

With a particular expertise in handling personal injury lawsuits, Levin Papantonio Thomas Mitchell Rafferty & Proctor, P.A. is currently involved in a number of litigation concerning various defective drugs. The Florida-based team includes Timothy O’Brien, whose recent victories include achieving an $8m verdict for a plaintiff who suffered osteonecrosis of the jaw arising from use of the drug Fosamax. O’Brien is currently acting in litigation alleging that use of the drug Invokana causes side effects of kidney damage, heart attacks and ketoacidosis. Ned McWilliams has been leading the team in lawsuits against Janssen and Bayer concerning the anticoagulent drug Xarelto, which plaintiffs allege cause fatal internal bleeding. Mike Papantonio is a highly regarded trial lawyer.

Lieff Cabraser Heimann & Bernstein, LLP continues to be involved in transvaginal surgical mesh litigation against various companies, among them Bard and Johnson & Johnson. The team includes Donald Arbitblit, who is experienced in serving on plaintiffs’ science and expert committees; he is a member of the plaintiffs’ steering committee in the Actos MDL. New York-based Wendy Fleishman has an impressive track record serving in leadership roles in significant MDLs in federal and state courts. The firm is currently representing clients in the first bellwether trial in the DePuy Pinnacle hip implant MDL. Other names to note are Elizabeth Cabraser and Robert Nelson. All partners are based in San Francisco unless otherwise stated.

The Lanier Law Firm has a strong track record in pharmaceutical and medical device personal injury litigation and is currently representing plaintiffs in various cases, such as Yaz/Yasmin lawsuits, testosterone therapy cases and the DePuy hip replacement litigation. W Mark Lanier served as co-counsel for plaintiffs in a two-month trial in the Western District of Louisiana arising from claims that use of the diabetes drug Actos caused plaintiffs to develop bladder cancer; the plaintiffs were awarded $9bn. Richard Meadow was also involved in successfully negotiating a $57m settlement with Bayer relating to claims that prescription birth control pills Yaz, Yasmin and Ocella caused life-altering side effects that include arterial blood clots. Robert Leone, Alex Brown and Los Angeles-based Lee Cirsch are also recommended.

Philadelphia-based Levin, Fishbein, Sedran & Berman, Frederick Longer is serving on the plaintiffs’ steering committee in the Xarelto litigation against the manufacturer Bayer and marketer Janssen arising from alleged failure to warn about risks. Michael Weinkowitz served as a member of the plaintiff negotiating committee in the Yaz/Yasmin litigation against Bayer, which resulted in a successful negotiation of a $57m settlement. Arnold Levin, Michael Fishbein, Howard Sedran and Laurence Berman are key figures.

New York-based Seeger Weiss LLP has a strong track record in a wide array of personal injury litigation involving defective pharmaceutical products and medical devices. It is representing plaintiffs against manufacturers in litigation concerning Accutane, Fosamax and Granuflo, among others, and is currently involved in medical device litigation regarding Mirena IUD, DePuy hip implants and transvaginal mesh. The well regarded David Buchanan, who has a particular expertise in electronic discovery, is currently serving in various leadership positions in coordinated litigation proceedings involving Accutane, DePuy hip implants and Yaz/Yasmin. Other key figures are co-founder Christopher Seeger and Jeffrey Grand, who has returned from Bernstein Liebhard LLP.

At Washington DC-based Ashcraft & Gerel LLP, trial veteran Michelle Parfitt is highly experienced in representing plaintiffs in numerous state and federal courts across the US. Christopher Tisi is leading the team in representing a plaintiff in the first trial against Johnson & Johnson and its subsidiary McNeil Consumer Healthcare regarding allegations that the defendants failed to adequately warn of risks of liver damage caused by taking high doses of Tylenol. James Green, whose experience includes arguing before the US Supreme Court, is also recommended. David LaCivita retired.

Montgomery-based Beasley, Allen, Crow, Methvin, Portis & Miles, P.C. is experienced in handling a broad range of litigation involving defective medical devices and unsafe medication. Navan Ward has been leading the firm’s involvement in the metal-on-metal hip implant litigation against Johnson & Johnson and DePuy Orthopedics, among others. Mass tort practice head Andy Birchfield is currently serving as co-lead counsel for the plaintiffs’ steering committee in the MDL concerning anticoagulant medication Xarelto. Frank Woodson and Matthew Teague are also recommended.

International comparative guides

Giving the in-house community greater insight to the law and regulations in different jurisdictions.

Select Practice Area

Client Intelligence Report

The Legal 500 United States - Events

GC Magazine

GC Powerlist -
United States

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Bulgaria: Opening the gas market for foreign traders!

    Most recently, the Bulgarian Energy Regulator has taken significant steps towards the full liberalisation of the natural gas market: In December 2016, the Bulgarian Energy Regulator adopted legislative amendments to the Rules for Trading of Natural Gas ( Правила за търговия с природен газ , " Trading Rules ") and the Rules for Access to the Gas Transmission and/or Gas Distribution Networks and the Natural Gas Storage Facilities ( Правила за предоставяне на достъп до газопреносните и/или газоразпределителните мрежи и за достъп до съоръженията за съхранение на природен газ , " Access Rules "). Moreover, it adopted new Rules for Balancing of the Natural Gas Market ( Правила за балансиране на пазара за природен газ , " Balancing Rules "). read more...
  • When Arbitration Meets Insolvency in Montenegro - Can They Coexist?

    Even at first blush, it is apparent that arbitration and insolvency make strange bedfellows.
  • Hungary: Registration Fees for Company Establishment Abolished

    In an aim to simplify state administration and support economic growth, the Hungarian Parliament adopted a new law abolishing the registration fee and the publication cost for incorporating limited liability companies (" LLC ") ( korlátolt felelősségű társaság ), limited partnerships ( betéti társaság ), general partnerships ( közkereseti társaság ), and sole entrepreneurships ( egyéni cég ). The new law becomes effective on 16 March 2017. read more...
  • SyCipLaw TMT Bulletin: Philippine Central Bank Issues New FinTech Rules

    The Bangko Sentral ng Pilipinas (BSP) (the Philippine Central Bank) has issued two new circulars that will be of interest to companies engaged in remittance services, e-money, digital currency, and other fintech businesses. Both circulars amend portions of the BSP Manual of Regulations for Non-Bank Financial Institutions.
  • IFLR: “Philippines: Foreign equity ownership decision”

    The March issue of the International Financial Law Review ( IFLR ) includes an international briefing article by SyCipLaw partner  Jose Florante M. Pamfilo  entitled “Philippines: Foreign equity ownership decision”. The article discusses the Philippine Supreme Court decision on the case of Roy v. Herbosa (GR no. 207246) to invalidate the Securities and Exchange Commission (SEC) Memorandum Circular no. 8-2013 (MC 8-2013) on the guidelines on compliance with the Filipino-foreign ownership requirements prescribed in the Philippine Constitution and/or existing laws by corporations engaged in nationalized and partly nationalized activities.
  • New regulation on unit-linked life insurance in Hungary

    Policyholders of unit-linked life insurance products pay an agreed sum for the unit-linked insurance to the insurance company, as a regular premium, or in one lump sum. These payments cover the life insurance component as well as the investment, administrative costs, contracting fee and the commissions. The "total cost charged" ("TCC") is an indicator – calculated in line with the rules of Hungarian insurance regulations – showing all costs charged on life insurance policies having a savings element, reflected as a percentage value. The regulation of the TCC in Hungary has been amended effective 1 January 2017. read more...
  • Hungary: Increase of Minimum Sale Price May Affect Retail NPL Transactions?

    On 7 March 2017, the Hungarian parliament adopted a law that increases the minimum sale price of a residential property in the enforcement procedure from the current 70% of its market value to 100% (market value to be understood as the price set by the appraisal of the bailiff), provided that (i) the claim to be enforced stems from a consumer contract; (ii) the real property is the debtor's only real property; and (iii) the debtor resided in that real property for at least six months prior to the initiation of the enforcement procedure.   read more...
  • European Court of Justice rules for the first time on discrimination based on belief

    The Court of Justice confirms a policy of neutrality can justify discrimination based on belief.

    Korean appeals court orders Google to disclose to Korean users what personal information Google passed to U.S. government.

    Case C-28/26 - Examines the right of a holding company to deduct input VAT on services acquired in the interest of its subsidiaries where those services are offered to its subsidiaries with no consideration.

Press Releases worldwide

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to